The contact activation system as a potential therapeutic target in patients with COVID‐19

Coronavirus disease 2019 (COVID‐19) is predicted to overwhelm health care capacity in the United States and worldwide, and, as such, interventions that could prevent clinical decompensation and respiratory compromise in infected patients are desperately needed. Excessive cytokine release and activat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Res Pract Thromb Haemost
Hlavní autoři: Shatzel, Joseph J., DeLoughery, Emma P., Lorentz, Christina U., Tucker, Erik I., Aslan, Joseph E., Hinds, Monica T., Gailani, David, Weitz, Jeffrey I., McCarty, Owen J. T., Gruber, Andras
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Forum
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264624/
https://ncbi.nlm.nih.gov/pubmed/32542210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12349
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky